Leucine

Studies of leucine in people

27 studies gave leucine to people and measured what changed

What changedDesignPeopleSource

up: Increases pS6/S6

down: Decreases LC3

Randomized trialMeal responses sampled through 3 h15 peopleadultsPatient cohortsAHA Scientific Sessions 2026 abstract, Nov 2, 2026

no change: Has no effect on body composition

no change: Has no effect on sarcopenic outcomes

Randomized trial28 days80 peoplemen60–89 yearsOlder men aged 60–89 years with a BMI ≥ 23.0 kg/mNutrients, Oct 2, 2026

no change: Has no effect on body composition

Randomized trial28 days80 peoplemen60–89 yearsOlder men aged 60–89 years with a BMI ≥ 23.0 kg/mPreprints.org, Sep 14, 2026

no change: Has no effect on skeletal muscle

Randomized trial4 weeks80 peopleMenyoung adultDuring alternate-day fastingPreprints.org, Aug 19, 2026

up: Increases leucineP < 0.001

Randomized trial≤4 h45 peopleMen69 ± 5 yOlder adultsThe Journal of nutrition, Aug 17, 2026

up: Improves handgrip strength

up: Increases skeletal muscle indexmodest increase, intervention group only

Randomized trial12 weeks24 peopleResponder rateKidney research and clinical practice, Jun 11, 2026

up: Increases appendicular skeletal muscle mass indexΔ 0.31 ± 0.13 vs. 0.08 ± 0.19 kg/m2, p = 0.01

no change: Has no effect on appendicular skeletal muscle mass index

no change: Has no effect on muscle strength

Randomized trial4 weeks18 peopleelderlyOlder adults; non-cancerClinical nutrition ESPEN, Mar 3, 2026

down: Decreases subjective perception of appetite

up: Increases IL-6

Randomized trialon the day of exercise and one day after12 peopleMenPatient cohortsNutrients, Feb 13, 2026

no change: Has no effect on muscle protein synthesis rates

no change: Has no effect on quadriceps cross-sectional areatreatment: P = 0.374 and P = 0.998

Randomized trial3 dBoth23 ± 4 y and 69 ± 4 yGeneral population; Older adults; 3 d unilateral knee immobilizationThe American journal of clinical nutrition, Jan 22, 2026

up: Increases leptinhigher concentrations in LEU group; p = 0.038

down: Decreases visfatinhigher concentrations in PLC group than LEU group; p = 0.020

Randomized trial10 weeks35 peopleWomenPostmenopausal women; leucine versus placebo group during resistance trainingJournal of strength and conditioning research, Dec 13, 2023

no change: Has no effect on frailtyCohen’s d: 0.04, p = 0.316

Randomized trial13 weeks41 peoplemost of them were women (n = 27, 66%)mean age 78.2 ± 9.1 yearsOlder (>65 years) participants with no dementia who were living in three nursing homes in Valencia, Spain, and able to walk 6 mGeriatrics (Basel, Switzerland), Oct 12, 2023

no change: Has no effect on muscle mass

no change: Has no effect on grip strength32.8 ± 9.9 to 32.8 ± 8.8 kg

up: Improves gait speedfrom 1.35 ± 0.20 to 1.41 ± 0.21 m/s

Trial12 weeks22 peopleseven out of 22 were female, accounting for 31.8% of total subjectsaverage of 55.3 years (range 27 to 72 years)Maintenance hemodialysis patientsFrontiers in nutrition, Apr 28, 2023

no change: Has no effect on short Physical Performance Battery score

no change: Has no effect on muscle mass

Randomized trial12 months145 peopleBothaged 70 years and overOlder people with sarcopeniaJournal of cachexia, sarcopenia and muscle, Feb 16, 2022

no change: Has no effect on muscle strength

Randomized trial24 weeks13 peopleWomen60-75 yearsOlder adultsThe journal of nutrition, health & aging, Jan 1, 2022

no change: Has no effect on muscle mass and function

Randomized trial16 weeks200 peopleWomenmean 72 ± 6 yearsOlder adultsClinical nutrition (Edinburgh, Scotland), Jul 3, 2021

up: Increases VDAC

Randomized trial12-week24 peoplewomen>65 yFrail or Pre-Frail community-dwelling elderly womenFrontiers in nutrition, Jan 22, 2021

no change: Has no effect on muscle strength

Randomized trial48 weeks60 peopleelderlyOlder adults; Patient cohortsEndocrine journal, Oct 17, 2020

no change: Has no effect on body weight loss

no change: Has no effect on resting metabolic rate

down: Decreases lean mass loss38% vs. 6% gained or maintained lean mass; p = 0.644

Randomized trial12 weeks34 peopleWomenmid-lifeMidlife adultsJournal of the American College of Nutrition, Oct 8, 2020

up: Improves functional performance

up: Improves lean mass index

up: Improves maximum static expiratory force

Randomized trial13 weeks50 people65 and overOlder adults; measured by walking timeNutrients, Mar 27, 2020

down: Decreases loss of leg lean mass-423 vs. -1035 ± 143 g; P = 0.008

no change: Has no effect on muscle strength and endurance

Randomized trial7 days bed rest plus 5 days rehabilitationBoth67.8 ± 1.1 yrOlder adults; 7-day bed restJournal of applied physiology (Bethesda, Md. : 1985), Mar 19, 2020

no change: Has no effect on muscle strength

no change: Has no effect on fat-free mass

no change: Has no effect on serum hormones

Randomized trial10 weeks36 peopleWomenperi- and postmenopausalMidlife adults; Postmenopausal womenJournal of the American College of Nutrition, Oct 2, 2019

no change: Has no effect on postprandial insulin and glucose area under the curve

Randomized trial3 months19 peopleWomen77.5 ± 1.3 yOlder adultsThe Journal of nutrition, Jun 1, 2019

up: Increases myofibrillar protein synthesis16% and 19% greater

Randomized trial6-h postexercise recovery24 peopleMen67 ± 1 yrOlder adults; coingested with 15 g milk protein after a single bout of resistance-type exerciseAmerican journal of physiology. Endocrinology and metabolism, May 21, 2019

up: Increases myofibrillar protein synthesis rate1.57% ± 0.11%/d vs 1.48% ± 0.08%/d

up: Increases blood leucine

Randomized trial3 days20 peopleMen65-85 yOlder adults; rested condition, in older men consuming lower- or higher-protein dietsThe American journal of clinical nutrition, Nov 9, 2016

no change: Has no effect on muscle protein fractional breakdown rateP > 0.05

Randomized trial24 h postexerciseMen72 ± 2 yrOlder adults; postexercise EAA ingestionJournal of applied physiology (Bethesda, Md. : 1985), Sep 1, 2016

up: Increases myofibrillar fractional synthesis ratepeak FSR 0.11 vs. 0.08 %.h.−1

up: Increases p70S6K1 phosphorylationfold-change 3.2 vs. 2.2

Randomized trial4 h after resistance exercise and feedingMen24 ± 6 yOlder adultsClinical nutrition (Edinburgh, Scotland), Apr 30, 2016

down: Protects against knee extensor muscle functionpeak torque -7% ± 3% vs -15% ± 2% control; endurance -2% ± 4% vs -14% ± 3% control

down: Prevents increase in body fat percentage

down: Decreases whole-body lean mass loss-0.8 ± 0.3 kg vs -1.5 ± 0.3 kg control at 7 d

Randomized trial14 d19 people52 ± 1 yMidlife adults; during 14 d of bed restThe American journal of clinical nutrition, Dec 30, 2015